Pfizer Provides Tepid Outlook As Q4 Results Miss Expectations

From Pfizer Inc. (NYSE:PFE) early Tuesday posted disappointing fourth quarter results and offered a tepid outlook, amid weakening demand for some of its key drugs.
NYSE:PFE January 31, 2017 7:14am

Pfizer Shares Drop 3.5% As Earnings, Outlook Disappoint

pfizer-pfe-logoPharmaceutical giant Pfizer Inc. (NYSE:PFE) this morning posted mixed third quarter results and adjusted its full-year outlook, which will likely fall short of expectations.
NYSE:PFE November 1, 2016 7:43am

Pfizer Shares Retreat After Company Decides Against Break-Up

Drug making giant Pfizer Inc. (NYSE:PFE) has decided against splitting into two separate publicly-traded entities, ending a multi-year vetting process aimed at unlocking shareholder value.
NYSE:PFE September 26, 2016 7:53am

Pfizer’s Spending Spree Continues with a $725 Million Antibiotics Acquisition

pfizer-pfe-logoFrom Zacks Research: Drug giant Pfizer Inc. (NYSE:PFE) continued its recent spending spree today, acquiring a rival's international anti-infectives business.
NYSE:PFE August 24, 2016 8:24am

Pfizer Wins the Medivation Auction, Will Acquire Company for $14 Billion

According to the Financial Times, drug giant Pfizer Inc. (NYSE:PFE) is set to acquire biotech standout Medivation Inc (NASDAQ:MDVN) for $14 billion, in a move that would heavily bolster Pfizer's cancer treatment portfolio.
NYSE:PFE August 22, 2016 7:08am

Pfizer’s Earnings Were Good, but Not Quite Good Enough

biotech-dnaDrug giant Pfizer Inc. (NYSE:PFE) on Tuesday posted estimate-beating earnings results and reaffirmed its full-year outlook, but the shares lost ground in early trading after a prolonged run-up heading into the report.
NYSE:PFE August 2, 2016 7:44am

Pfizer Surges to 12-Year Highs, Acquires Gene Therapy Company

drugsDrugmaker Pfizer Inc. (NYSE:PFE) on Monday announced the acquisition of a gene therapy company Bamboo Therapeutics, which helped spike PFE to its highest levels since 2004.
NYSE:PFE August 1, 2016 11:35am

As Pfizer Inc.-Allergan plc Ordinary Shares Sinks, These “Inversion” Deals Could Be Next

backroomdeals600X300Tyler Durden:  While the surge in Q1 market volatility has had a dramatic impact on asset prices, and led to some unprecedented central bank interventions to stabilize markets, one product that has seen a dramatic hit and has yet to rebound, is M&A.
ETF BASIC NEWS April 7, 2016 12:02pm

Pfizer Inc. (PFE), Allergan plc Ordinary Shares (AGN) Terminate $160 Billion “Inversion” Merger; Banks Lose Over $100MM In Fees

deal handshakeTyler Durden:  Less than two days after the US Treasury cracked down on inversion deals, and one deal in particular, Pfizer's pharma record $160 billion acquisition of Allergan, moments ago the two companies announced the deal is officially over.

Is The Allergan plc Ordinary Shares-Pfizer Inc. Deal Over?

backroomdeals600X300Tyler Durden:  Yesterday's stunning announcement by the US Treasury, which released a report titled  "Treasury Announces Additional Action to Curb Inversions, Address Earnings Stripping", and which was clearly aimed at ending not only all tax inversions,
ETF BASIC NEWS April 5, 2016 11:07am

Top-Dog Dividend Stocks For 2016

Wall streetMike Burnick:  With 2015 ending tonight at the stroke of midnight, it was a lackluster year for stocks. The Dow Jones Industrial Average is on track for a decline of 0.8% this year (as of Wednesday’s close). Meanwhile, the small-cap Russell 2000 Index is down nearly 4% year to date.
NYSE:DOD January 4, 2016 12:57pm

Is The Pfizer Inc. (PFE) Dividend In Jeopardy?

dividends1Steve Mauzy:  When I got wind of the $160 billion mega-merger of pharmaceutical colossi Pfizer Inc. (NYSE: PFE) andAllergen PLC (NYSE: AGN), two thoughts sprang immediately to mind. One conjured the sage words of a college finance professor, who said, “Economics should always supersede taxes in financial decisions.”
ETF BASIC NEWS December 11, 2015 3:06pm

Pfizer Inc. (PFE): Why The Stock Price Will Head Higher After Merger

deal handshakeDiane Alter:   The Pfizer stock price is up 0.5% today as the U.S. drug giant remains in advanced stages to buy Allergan Plc. (NYSE:AGN). Pfizer Inc. (NYSE:PFE) is pushing forward with the deal despite the best wishes of the U.S. Treasury, which is trying to curb such mergers.
ETF BASIC NEWS November 23, 2015 3:09pm

The Best Way To Play The Looming Superbug Threat [GlaxoSmithKline plc (ADR), Pfizer Inc., Cempra Inc, Eli Lilly and Co]

biotechTony Daltorio:  Jim O’Neill, the former chief economist at Goldman Sachs, is best known for coining the BRIC acronym, which stands for the emerging market countries Brazil, Russia, India and China.
ETF BASIC NEWS June 29, 2015 3:14pm

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories